Home/Filings/4/0001209191-19-006862
4//SEC Filing

Levy Howard 4

Accession 0001209191-19-006862

CIK 0001124105other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:53 PM ET

Size

6.9 KB

Accession

0001209191-19-006862

Insider Transaction Report

Form 4
Period: 2019-01-31
Levy Howard
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-01-31$4.63/sh+1,500$6,9459,382 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-01-311,50093,500 total
    Exercise: $4.63Exp: 2027-07-11Common Stock (1,500 underlying)
Footnotes (1)
  • [F1]The Option vests monthly over a period of four years commencing June 15, 2017.

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001672333

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:53 PM ET
Size
6.9 KB